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Abstract
The incidence of acute pancreatitis is increasing in children and it should be con-
sidered as part of differential diagnosis in case of abdominal pain. The etiology of 
acute pancreatitis in this subpopulation is related to several conditions and risk fac-
tors, such as drugs, obesity, infections, trauma and anatomic abnormalities. In older 
children abdominal pain is the first symptom in more than 90% of cases, where as 
in younger children vomiting represents an early clinical manifestation. Diagnosis is 
based on laboratory investigation, such as serum levels of lipase, and imaging find-
ings (ultrasonography, CT scanning or MRI) such as detecting edema, hemorrage 
or necrosis of pancreatic parenchyma or in peripancreatic fat. Treatments for adults 
and children are similar. Rapid and accurate assessment of the severity of pancreati-
tis is absolutely indicated for selecting the appropriate treatment and predicting the 
prognosis.
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1. Introduction
Pediatric pancreatitis has increased in incidence during last decades and 
1/10,000 children per year is affected by the acute form genetic mutations and 
congenital abnormalities represent the major risk factors for this disease but there 
is no agreement about a certain pathogenetic theory. The reasons of pancreatitis’ 
burden in pediatric population may be multifactorial and it can be explained by an 
improved detection instead of a real increase [1].
In children, pancreatitis is categorized as acute pancreatitis (AP), acute recur-
rent pancreatitis (ARP) and chronic pancreatitis (CP). Here we summarize recent 
advances in the field of pediatric pancreatitis with focus on etiologies, pathogenesis, 
diagnosis and therapy.
2. Acute pancreatitis
Acute pancreatitis (AP), in children is increasingly recognized to be a challenge 
for affected patients and their families, their treating physicians and surgeons, and 
the health care system. The incidence of pediatric AP was estimated at 3.6–13.2 per 
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100,000 per children per year, which is within of the range of incidence reported 
for adult AP. Genetic contributions to the development of pancreatitis, especially 
in acute recurrent and chronic pancreatitis are now increasingly recognized. There 
are no evidence-based diagnostic guidelines for pancreatic disorders in children. 
The diagnosis criteria are based on symptoms, biochemical and imaging evidence 
of pancreatitis, with two of the three criteria required to diagnose AP. A multicenter 
effort led by INSPPIRE (INternational Study Group of Pediatric Pancreatitis: In 
Search for a CuRE) defined AP as requiring 2 of: (1) abdominal pain compatible 
with AP, (2) serum amylase and/or lipase values ≥3 times upper limits of normal, 
(3) imaging findings consistent with AP. Although abdominal pain is the most com-
mon clinical manifestation, it may be absent in up to one third of pediatric patients. 
The diagnostic yield and concordances for serum pancreatic enzymes and imaging 
for the diagnosis of pediatric AP will be discusses. Pediatric AP is associated with 
significant disease burden. There is currently no consensus on the definition for 
severity of AP in children. However, there are now predictors of severity for AP 
that has been developed and validated in children. The management of AP remains 
driven by adult studies and recommendations. Treatment is directed at the underly-
ing etiologies as well as supportive measures.
2.1 Etiology
While alcohol and gallstones represent the main causes of acute pancreatitis 
in adult population, the etiological scenario of acute pancreatitis is mostly due 
to drugs, infectious diseases, congenital abnormalities or trauma (Table 1). 
Furthermore etiological factors may vary considerably according with ethnicity.
2.1.1 Infections
Pediatric acute pancreatitis is associated with paramyxovirus or mycoplasma 
infections. Mumps virus induces parotitis and orchitis in pediatric population and 
may be complicated by meningoencephalitis or pancreatitis. In the latter case clini-
cal manifestations are represented by usually self-limiting diarrhea and abdominal 
pain. Mycoplasma infection-related pancreatitis can be distinguished into two types: 
early onset type and late-onset type following respiratory tract symptoms begin-
ning. This different onset spectrum is due to a direct injury of mycoplasma into the 
acinar cells in the former type while to an autoantibodies targeting in the latter [2].
2.1.2 Congenital abnormalities
Chole-dochal cyst constitutes the most principal cause of AP. In case of abnor-
mal junction between pancreatic and biliary ducts the sphincter of Oddi encircles 
Common Less common Rare
Biliary disorders Infections Autoimmune pancreatitis
Systemic conditions Metabolic diseases Anatomic pancreatobiliary abnormalities
Medications Genetic/hereditary
Trauma
Idiopathic
Table 1. 
Causes of acute pancreatitis in children.
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a single channel leading to bile reflux into the Wirsung duct is communication 
between in course of sphincter contraction or bilestone impingement in the com-
mon channel [3].
2.1.3 Drugs and chemotherapeutic agents
Drug-induced acute pancreatitis accounts for 21% of all cases in pediatric 
population. Valproic acid, radiocontrast and corticosteroids can induce pancreatitis 
in the context of epilepsy or inflammatory bowel diseases [4].
L-asparaginase-associated pancreatitis (AAP) occurs in 0.7–24% of children 
treated for acute lymphoblastic leukemia with mortality rates of 2–5%. Older 
children demonstrate an high risk for developing acute pancreatitis and if it occurs 
they could experience cancer recurrence [5].
2.1.4 Trauma
Pediatric pancreatic injuries are uncommon and can be mostly ascribed to 
vehicle accidents. Anyway because of its retroperitoneal location pancreas is pre-
served in case of minor abdominal traumas and a pancreatic transection can occur 
clinically silent [6].
2.2 Pathophysiology
Acute pancreatitis is due to an organ injury with a subsequent inflammatory 
response that may involve both adjacent and distant structures. The first pathoge-
netic event may be represented by an acinar cell injury (Figure 1) that produces 
pancreatic edema with the activation of the inflammatory pathway. The release of 
cytokines and chemokines leads to a systemic inflammatory response (SIRS) and to 
complications such as pancreatic necrosis, shock and distant organ failure.
Several hypotheses have been advanced explaining the mechanism of this acinar 
cell damage. The autodigestion model focused on a premature calcium-mediated 
intracellular trypsinogen activation in trypsin (Figure 1). Trypsin then activates 
digestive enzymes that mediate acinar cell injury. On the other hand, recent studies 
in animal models of AP highlight the pathogenetic role of colocalized zymogens and 
lysosomes, intra acinar activation of zymogens, nuclear factor-κb activation and 
inhibition of secretion [7].
Figure 1. 
Pathophysiology of acute pancreatitis.
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2.3 Diagnosis
The diagnosis of AP in children depends on clinical manifestations, laboratory 
tests, and imaging. Moreover a careful estimation of severity is fundamental for 
establish the most appropriate treatment (Figure 2).
2.3.1 Clinical features
There are differences in clinical onset and natural course between adults and 
children. Acute pancreatitis symptoms are non-specific and depend on child’s 
age and developmental level. Abdominal pain is typically epigastric but it can be 
localized to the right upper quadrant or left upper one. It can occur constantly 
or intermittently, with radiation to the back. The pain is dull, boring and deep. 
Pancreatitis should be suspected in all pediatric patients who experience, as isolated 
or combined symptoms, abdominal pain, nausea and/or vomit, the latter due to 
peripancreatic inflammation extended to the gastric wall [8].
Figure 2. 
Pediatric acute pancreatitis diagnostic flow chart.
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2.3.2 Biochemical tests
The increased serum levels of amylase enzyme greater than three upper limits 
of normal are also detected in case of pancreatobiliary tract obstruction and 
perforative peritonitis, in addition to salivary gland pathologies and renal failure. 
Therefore this parameter is associated with a low specificity. On the other hand 
serum lipase levels have a sensitivity of 86.5–100% and specificity of 84.7–99.0%. 
In case of severe pancreatitis, serum lipase levels seven times higher than normal 
have been detected within the first 24 h. It is important to underline that in case of 
drug-induced acute pancreatitis serum amylase may not be elevate [9]. In addition, 
we may consider other chemistry panels to define a diagnosis like serum calcium, 
electrolytes, urea nitrogen, creatinine, transaminases, albumin, bilirubin, triglycer-
ides and blood cell count [10].
2.3.3 Diagnostic imaging
Transabdominal ultrasound is the diagnostic study of choice to evaluate biliary 
tree abnormalities in children. In pediatric age pancreatic head tend to be larger 
than body and tail and this is a potentially confounding feature that may lead to a 
misdiagnosis. Diffuse or focal enlargement of the pancreatic gland may be pres-
ent in AP and is attributable to edema. Echogenicity is a variable feature in case of 
pediatric pancreatitis, however hypoechogenicity is frequently seen.
One of the most valid radiological finding is represented by the dilatation of 
the pancreatic duct (1–6 years old, >1.5 mm; 7–12 years old, >1.9 mm; 13–18 years, 
>2.2 mm). Poorly defined borders or localized intraparenchymal fluid collection are 
usually detected at ultrasound imaging in the acute setting.
Parenchymal hypodensities, heterogeneity, irregularity of the glandular margins 
and inflammatory changes in the peripancreatic fat could be seen at CT (computed 
tomography) scans. The use of intravenous contrast is mandatory to evaluate differ-
ent grades of glandular involvement and patency of adjacent vessels. Furthermore, 
CT imaging may show the extent of peripancreatic or intraparenchymal fluid 
collections and the presence abscessualization.
Magnetic resonance cholangiopancreatography (MRCP) is challenging o 
perform in pediatric patients and needs to be tailored to different body sizes. The 
pancreatic glands become heterogeneous and hypointense on T1-weighted images 
in the early stages of inflammation [11].
2.3.4 Severity assessment
Commonly used scoring systems (Ranson, modified Glasgow and pediatric 
acute pancreatitis severity) have demonstrated limited ability to predict disease 
severity in children and adolescents with acute pancreatitis. The sensitivity and 
negative predictive value of the above scores are insufficient to guide decision mak-
ing in pediatric patients. Therefore better methods are needed for risk stratification. 
Anyway, in a logistic regression model [12], only white blood cell count at admission 
more than 18,500/mcL, trough calcium less than 8.3 mg/dL and blood urea nitrogen 
greater than 5 mg/dL appear to correspond independently with a poor outcome.
The lack of an accurate scoring system could cause delays in appropriate clinical 
management and increase the risk of progressive life-threatening complications. 
In recent years Suzuki [13] has investigated a modified score that reflects pediatric 
SIRS (systemic inflammatory response syndrome) score, age and weight (Figure 3) 
and it has proved a more adequate scoring system in children, helping to improve 
treatment outcome in these patients.
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2.3.5 Complications
The most frequent complication of acute pancreatitis in pediatric age is repre-
sented by the development of pseudocysts and occurs in 13% of patients (Figure 4). 
This is a delayed complication and occurs 4 weeks after the onset of the acute 
inflammatory process. Pseudocysts probably arise from disruption of the main 
pancreatic duct, leading to an oval fluid collection with a well-defined wall in the 
peripancreatic tissues. The early alteration that involves pancreatic tissue in the set-
ting of an interstitial edematous pancreatitis (IEP) is the formation of peripancre-
atic fluid collections that may resolve spontaneously. A necrotizing process arising 
in the pancreatic parenchyma or in adjacent tissues results in the development of 
multiple necrotic collections walled-off with an increased risk of infection.
Vascular complications may involve the arterial or venous system and are caused 
by extravasated pancreatic enzymes with the loss of vessel wall integrity. Thus hemor-
rhage secondary to the rupture of a pseudoaneurysm or erosion of a major artery may 
occur. Moreover, in the venous system, thrombosis is a complication that commonly 
affects the splenic vein. Pancreatic ascites and pancreaticopleural fistulas are two 
uncommon types of internal pancreatic fistulas resulting from pancreatic duct disrup-
tion with leakage of pancreatic fluid. Since complications are similar to those occur-
ring in adults the revised Atlanta classification (Figure 5) is useful in children too [11].
Intra-abdominal hypertension (IAH) and abdominal compartment syndrome 
(ACS) are rare in children with severe acute pancreatitis but still have high mortal-
ity rates.
The increased abdominal pressure leads to alteration in microvasculature 
determining ischemia, congestion and edema of the organs. Thus the consequent 
Figure 3. 
Japanese scoring system to assess severity of acute pancreatitis.
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bacterial shift into the bloodstream causes bacteremia, systemic inflammatory 
response and hemodynamic instability. The purpose of management of critical 
pediatric patients is to avoid ACS progression and the development of multi-organ 
dysfunction syndrome [14].
2.4 Treatment
2.4.1 Drug therapy
Children with AP should be resuscitated with crystalloids and be provided 
1.5–2 times maintenance intravenous fluids with monitoring of urine output 
Figure 4. 
Pancreatic pseudocyst at contrast-enhanced CT scan in a 6-year old patient.
Figure 5. 
Revised Atlanta classification of complications in AP. IEP: interstitial edematous pancreatitis; APFC: acute 
peripancreatic fluid collection; ANC: acute necrotic collection; WON: walled-off necrosis.
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over the next 24–48 h. Monitoring of patients with acute pancreatitis can provide 
indicators of complications arising, including SIRS and organ dysfunction/failure. 
Cardiac, respiratory, and renal status should be followed particularly closely within 
the first 48 h. Opioid analgesics in oral or parenteral forms are required for pain 
control in acute pancreatitis. Despite previous contentions, there is no evidence 
about the paradoxical contraction of the sphincter of Oddi induced by morphin 
and it should be used for acute pancreatitis pain not responding to acetaminophen 
or NSAIDs (non steroids anti-inflammatory drugs). In pediatric patients with a 
diagnosis of mild acute pancreatitis oral feedings or enteral nutrition (EN) can be 
started within 24–48 h. Parenteral nutrition (PN) should be considered in cases 
where EN is not possible for a prolonged period (longer than 5–7 days) such as in 
ileus, complex fistulae, abdominal compartment syndrome, to reduce the catabolic 
state of the body.
Antibiotics should not be used in the management of AP, except in the presence 
of documented infected necrosis, or in patients with necrotizing pancreatitis who 
are not improving clinically without antibiotic use. Antibiotics known to penetrate 
necrotic tissue (such as carbapenems, quinolones and metronidazole) should be used 
in management of infected pancreatic necrosis as these may delay surgical interven-
tion and decrease morbidity and mortality. Instead antiprotease or antioxidants are 
not recommended in the management of acute pancreatitis in children [15].
2.4.2 Nutritional strategy
In severe pancreatitis an earlier oral re-feeding reduces the incidence of infec-
tions and contributes to a shorter hospitalization. Serum pancreatic enzymes’ level 
tips the balance in the enteral feeding strategy. If serum amylase and lipase are 
decreasing liquid intake can be started, according with clinical conditions, while if 
they are minor than two times the upper normal values, an hypolipidic diet should 
be considered [13].
2.4.3 Endoscopic and surgical treatment
Undoubtedly anatomic abnormalities are an indication for surgery while 
ampulla of Vater anomalies or pancreatic divisum may be eligible for an endoscopic 
sphincterotomy. In patients with infected necrosis of the pancreatic gland a necro-
sectomy is mandatory in case of worsening clinical conditions and unresponsive-
ness to therapeutic measures. However this procedure (percutaneous, endoscopic or 
laparoscopic necrosectomy) has an high mortality rate and should be performed in 
hemodynamically stable patients.
Pancreatic pseudocysts are cysts that develop due to injury of the pancreatic duct 
and extravasation of fluid. These occur 4 weeks or later after the onset of pancre-
atitis. Treatment is indicated for pseudocysts if their size does not decrease, if they 
are accompanied by abdominal pain, or if there are complications of infection or 
hemorrhage. Whereas endoscopic ultrasound-guided transgastric drainage can 
safely be considered in case of growing pancreatic pseudocysts or in case of hemor-
rhagic complications [13].
3. Acute recurrent pancreatitis
Approximately 10–20% of pediatric patients experience recurrent episodes of 
acute pancreatitis beneath which it is possible to identify an idiopathic or structural 
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etiology. ARP may evolve in the chronic form that is clinically indistinguishable 
from acute pancreatitis in children [16].
3.1 Etiology
Risk factors that predispose to ARP can be categorized according the follow-
ing frequency in: genetic, obstructive, metabolic and autoimmune [17]. However 
the etiology of ARP remains unexplained in 30% of cases and can be classified as 
“idiopathic” is used.
3.1.1 Genetic causes
Genetic conditions that predispose to recurrent episodes of pancreatitis are the 
cystic fibrosis transmembrane conductance regulator-gene (CFTR-gene), PRSS1-
gene and SPINK1-gene mutations.
CFTR-gene mutations occur in about 5% of Western populations and cause an 
altered function of the product of this gene with a defect in the transmembrane 
epithelial chloride ion transfer. This dysregulation affects different organs including 
the pancreas and results in an abnormal production of viscous exocrine secre-
tions that lead to ductal obstructions. Mutations in the cationic trypsinogen gene 
(PRSS1-gene) have been matched in patients with hereditary pancreatitis. The 
pancreas is unable to contrast an excessive trypsin activation because of the lack of 
protective mechanism predisposing patients to recurrent episodes of pancreatitis in 
childhood.
SPINK1-gene mutations predispose to the development pancreatitis and involve 
the serine protease inhibitor Kazal type I gene (SPINK1). This mutation results in 
a defect of the protective action in the pancreas mediated by SPINK1 protein that 
represents a feedback inhibitor of trypsin activation. Approximately 16–23% of 
patients with idiopathic pancreatitis have SPINK1 mutations instead [18].
3.1.2 Anatomical anomalies
Pancreas divisum is the most frequent anatomical variant and has an incidence 
near to 12% in general population. As a result of this incomplete fusion of the 
ventral and dorsal ducts pancreatic juices cause ductal hypertension. Patients 
may experience recurrent pain after food intake, an alteration in serum content 
of pancreatic enzymes, or acute recurrent pancreatitis. Annular pancreas is 
another anatomical variant that may be related with duodenal or biliary obstruc-
tive symptoms. Ductal abnormalities such as a common pancreatico-biliary 
channel may determine a bile or pancreatic juices reflux and can be diagnosed 
with ERCP. Sphincter of Oddi dysfunction (SOD) is another factor predispos-
ing to ARP and is probably the most common cause of the idiopathic form. This 
dysfunction includes two clinical forms: SO increased basal pressure related to 
a structural fibrotic alteration of the sphincter and SO dyskinesia, caused by 
sphincter  hypertone [19].
3.1.3 Metabolic disorders
Toxic and metabolic factors such as hypercalcemia, hypertriglyceridemia, 
diabetes, porphyria and Wilson’s disease can predispose to the development of acute 
recurrent episodes of pancreatitis as well as medications (i.e., azathioprine and 
6-mercaptopurine) [17].
Pancreatitis
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3.1.4 Autoimmune disorders
Autoimmune pancreatitis is an increasingly recognized disease entity associated 
with hypergammaglobulinemia. High serum levels of IgG4 are suggestive of AIP in 
adults while just 22% of pediatric patients have immunoglobulin levels above the 
upper limits of normal [19]. AIP can be classified into two types: type one lympho-
plasmacytic sclerosing pancreatitis and type two idiopathic duct-centric pancre-
atitis. The latter form seems to be more frequent in children and it is associated 
with inflammatory bowel syndrome. Anyway this distinctive type of pancreatitis is 
responsive to corticosteroid therapy.
3.2 Clinical features and diagnosis
ARP can be defined as two or more episodes of acute pancreatitis occurring with 
complete resolution of symptoms in between (>1 month between two episodes) 
or normalization of pancreatic enzymes serum levels in the time interval, with not 
detected radiological signs of chronic pancreatitis. ARP should be considered in 
the diagnostic process of children with a positive anamnesis for recurrent gastro-
enteritis with vomiting, epigastric pain, or irritable bowel syndrome. An early 
identification of the underlying etiology may lead to a complete resolution of the 
disease [18].
The most common risk factors in childhood are genetic mutations so gene 
testing is mandatory and a chloride sweat test is helpful to diagnose a CF (cystic 
fibrosis).
The patient’s anamnesis and standard laboratory tests, trans-abdominal ultra-
sound, MRCP, and CT scan can easily detect the causes of recurrent pancreatitis in 
about 70% of cases. The remaining 30% of patients should have further investiga-
tions such as genetic testing, MRCP (magnetic resonance cholangiopancreatogra-
phy), that provides the potential to delineate ductal anatomy without the risks of 
contrast injection, EUS (Endoscopic UltraSonography) and ERCP, that represents 
the most accurate imaging to define the pancreas anatomy. Genetic and autoim-
mune pancreatitis can be diagnosed by sequencing CFTR or SPINK1/PRSS1 gene 
mutations and IgG4.
3.3 Treatment
Therapeutic approach to recurrent pancreatitis associated with pancreas divi-
sum is based on endoscopic and surgical procedures. Both strategies are effective 
in 70–90% so the former therapy is preferred. Surgery may include accessory duct 
sphincteroplasty alone or in combination with major sphincteroplasty and septo-
plasty. Patients with distal ductal obstruction or ductal ectasia may take advantage 
from pancreaticojejunostomy [20]. Annular pancreas is another congenital aletara-
tion of the pancreatic ductal system and surgical resection represents the preferen-
tial treatment. Recurrent pancreatitis associated with the CFTR-gene mutation of 
hereditary pancreatitis may be prevented by endoscopic pancreatic sphincterotomy 
reducing intraductal hypertension.
Furthermore, in last years, many efforts have been made to identify a novel 
therapy for lipoprotein lipase deficiency (LPLD), a genetic disease causing chylo-
micronemia and an increased risk for developing acute and recurrent pancreatitis. 
Thus alipogene tiparvovec (Glybera) gene therapy has definitely proven to be effec-
tive in reducing frequency and severity of pancreatitis events [21].
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4. Chronic pancreatitis
Pediatric chronic pancreatitis is unusual and the incidence increases with age 
(0.5 per 100,000 in young adults) but this condition presents a progressive behavior 
and is poorly responsive to therapy.
Chronic pancreatitis has been defined as a persistent inflammatory injury of the 
pancreas characterized by irreversible architectural changes that cause pain and/or 
irreversible loss of function [22].
4.1 Etiology
As mentioned above genetic mutations are the most common causative factors 
for pancreatitis in children despite other risk factors may be brought into play as 
the TIGAR-O classification system well explained and categorized according to 
toxic-metabolic causes, idiopathic, genetic, autoimmune and obstructive chronic 
pancreatitis [23]. Within the last years, multiple studies have reported rates of 
genetic mutations associated with pancreatitis, involving CFTR, SPINK1 and PRSS1 
genes, from 36 to 73%. So future perspectives will certainly focus on a personal-
ized medicine approach in order to define a more specific and targeted treatment. 
Cationic trypsinogen PRSS1 is the gene most frequently involved in the evolution 
to the end stage of chronic pancreatitis. Near to 80% of individuals with either 
the R122H or N29I gain of function mutation develop at least one episode of acute 
pancreatitis and half of clinically affected individuals with either the R122H or N29I 
mutation will evolve to chronic pancreatitis.
Moreover pancreas divisum represents an obstructive cofactor in the develop-
ment of chronic involutional changes of the pancreatic gland.
4.2 Pathology
Parenchymal fibrosis, with loss of acinar cells, results in exocrine pancreatic 
insufficiency (EPI) as a late stage of the disease and needs to be treated with 
pancreatic enzyme replacement therapies. Then normal acini are replaced by 
fibroblasts and lymphocytic infiltration. Furthermore, progressively endocrine cells 
are damaged too resulting in diabetes mellitus (DM) that often occurs post chronic 
pancreatitis [23].
4.3 Diagnosis
According with INSPPIRE data the definition of chronic pediatric pancreatitis 
depends upon one of the following: (1) abdominal pain and imaging findings that 
can suggest a chronic pancreatic damage; (2) evidence of exocrine pancreatic insuf-
ficiency with maldigestions symptoms and diagnostic imaging suggestive for pancre-
atic damage; (3) evidence of pancreatic islets dysfunction and imaging findings that 
can suggest the presence of a pancreatic damage; or (4) a surgical or pancreatic biopsy 
demonstrating pathological features compatible with chronic pancreatitis [24].
4.3.1 Imaging findings
The most commonly found radiographic signs of chronic pancreatitis in children 
are represented by ductal anomalies and pancreatic gland atrophy. Unlike the adult 
form, pancreatic calcifications are not detected in childhood chronic pancreatitis. 
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To reduce the exposure to ionizing radiation MRI/MRCP and ultrasound (US) 
are preferred. ERCP, as in adults, can be considered for procedures such as stone 
removal or stricture dilation [23].
4.3.2 Pancreatic function tests
Altered pancreatic function tests are diagnostic of chronic pancreatitis but 
also are detected in case of other clinical conditions such as pancreatic agenesis or 
resection, intestinal atrophy, kwashiorkor and gastrinoma. We also have to consider 
mild or moderate forms of chronic pancreatitis in case of normal tests. Exocrine 
pancreatic function can be assessed by direct or indirect evaluations. Direct tests 
pancreatic such as the secretin-cholecystokinin test have the highest sensitivity and 
specificity but at the same time they are inadequate for routine clinical practice in 
pediatric population. On the other hand indirect tests are noninvasive and routinely 
used. Indirect pancreatic function test can be divided in three main groups:
1. Analysis of the hydrolyzed products of pancreatic enzymes’ activity detectable 
in urine and serum (NBT-PABA test, pancreolauryl test);
2. Assessment of undigested and unabsorbed food components in feces (fecal fat 
excretion and fecal fat concentration);
3. Dosage of pancreatic enzymes in the serum (amylase, isoamylase, lipase, 
trypsinogen, elastase-1) or stool (chymotrypsin, lipase, elastase-1).
Fecal elastase-1 (FE1) is the most sensitive test in the evaluation of exocrine 
pancreatic function in chronic pancreatitis [25].
Fecal elastase-1 is a proteolytic pancreatic enzyme that is not degraded during its 
passage through the gastrointestinal tract. Analysis of FE1 is simple and practical to 
be managed but it may be compromised in case of diarrhea, with an associated risk 
of falsely low FE1 concentration [26].
4.3.3 Biopsy
A pancreatic EUS-guided biopsy may represent the gold standard for the diag-
nosis of chronic pancreatitis but it is not widely available.
And besides some etiologies of chronic pancreatitis, such as autoimmune or 
hereditary pancreatitis, need multiple biopsies to be diagnostic. At histological 
examination irregular fibrosis can be seen while intralobular fibrosis alone is not 
specific for chronic pancreatitis [22].
4.4 Treatment
Both the stage and etiology of CP influence its management. With disease 
progression, chronic pain management and treatment of pancreatic insufficiency 
or diabetes are required. Acetaminophen may be effective in the early stages, 
but therapy generally advances to narcotics. Pancreatic enzyme supplements 
and antioxidant therapy (selenium, ascorbic acid, b-carotene, a-tocopherol, and 
methionine) are prescribed frequently in this setting. Endoscopic treatment for CP 
should be considered only when ductal strictures or pancreatic duct calculi are pres-
ent or for symptomatic pseudocysts. Surgical treatment is still indicated in selected 
patients when conservative treatment failed. Localized disease can be treated with 
partial pancreatic resection (i.e., in case of a pancreatic inflammatory head mass) 
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while radical pancreatectomy with islet cell autotransplant is currently offered to 
patients who have genetic causes of pancreatitis (as we’ll describe in the next sec-
tion). A longitudinal pancreaticojejunostomy (known as modified Puestow proce-
dure) can be definitely avoided. Although many patients have pain relief, a number 
of patients continue to have pain. In up to 20% of adults, the pain is as intense as it 
was before the resection. Preadolescents are more likely to be insulin-independent 
than older children and adults. Thus time to surgical procedure is fundamental to 
avoid a progressive decrease in islet cell yield. Pancreatic insufficiency is treated 
with pancreatic enzyme replacement therapy. The final goal is to restore digestive 
function and maintain weight gain.
4.4.1 Total pancreatectomy with islet autotransplantation (TPIAT)
Children with chronic pancreatitis who suffer recurrent severe episodes of 
abdominal pain, chronic use of analgesics (opioids) and frequent hospitalizations 
may benefit from TPIAT, in order to improve their quality of life. A multidisci-
plinary team including gastroenterologists, endocrinologists, surgeons, anesthesi-
ologists, psychologists, radiologists and nutritionists guides the selection of these 
patients.
Thus the procedure consists in a demolitive operative phase, followed by a 
reconstructive one that includes an hepaticojejunostomy plus gastrojejunostomy or 
a duodenojejunostomy and the autotransplantation of islets via the portal vein.
Osmotic, mechanical or hypoxia damage of islets should be considered, espe-
cially in the pre-engraftment phase and the risk of developing diabetes mellitus 
must be accepted by families.
Anyway pain resolution, independence from analgesics and significant improve-
ment in quality of life has been reported in the majority of children with CP follow-
ing TPIAT, and glycemic control is managed without difficulty [24, 27].
5. Conclusions
The incidence of acute pancreatitis is increasing in children and it should be 
considered as part of differential diagnosis in case of abdominal pain. The etiology 
of acute pancreatitis in this subpopulation is related to several conditions and risk 
factors, such as drugs, obesity, infections, trauma and anatomic abnormalities but 
genetic predisposition represents the master causative factor.
Rapid and accurate assessment of severity is useful for selecting an appropriate 
initial treatment and predicting the prognosis. The International Study Group for 
Pediatric Pancreatitis: In Search for a Cure (INSPPIRE) focused on ARP and CP in 
pediatrics and we can delineate more accurately clinical presentations, risk factors 
and natural history of pediatric pancreatitis to define a more appropriate therapeu-
tic strategy, often considering that a children is not a small adult.
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